Oral live attenuated human rotavirus vaccine (RotarixTM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

Oral live attenuated human rotavirus vaccine (RotarixTM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

In a large Phase III trial conducted in 10 Latin American countries, the safety and efficacy of the live attenuated monovalent rotavirus vaccine RIX4414 was evaluated in 15,183 healthy infants followed up during the first two years of life. Belém was the only site in Brazil included in this multicen...

Full description

Bibliographic Details
Main Authors: Maria Cleonice A Justino, Eliete C Araújo, Leen-Jan van Doorn, Consuelo S Oliveira, Yvone B Gabbay, Joana D'Arc P Mascarenhas, Yllen S Miranda, Sylvia de Fátima S Guerra, Veronilce B da Silva, Alexandre C Linhares
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2012-11-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
rotavirus
gastroenteritis
vaccine efficacy
G9P[8] strains
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000700002&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000700002&lng=en&tlng=en

Similar Items